© 2023 BioMarin. All rights reserved.

Analyst Coverage

BioMarin Pharmaceutical Inc. is covered by the following analysts.

Firm Analyst
BofA Securities, Inc. Geoff Meacham
Barclays Gena Wang
BMO Capital Markets Kostas Biliouris
Canaccord Whitney Ijem
Cantor Fitzgerald Olivia Brayer
Citigroup David Lebowitz
Cowen & Company Philip Nadeau
Credit Suisse Tiago Fauth
Evercore ISI Joshua Schimmer
Goldman Sachs Salveen Richter
Guggenheim Debjit Chattopadhyay
Jefferies Akash Tewari
JP Morgan Jessica Fye
Morgan Stanley Matthew Harrison
Morningstar Karen Andersen
Oppenheimer Leland Gershell
Piper Sandler Christopher Raymond
RBC Luca Issi
RW Baird Joel Beatty
Stifel Paul Matteis
SVB Leerink Joseph P. Schwartz
Truist Securities Robyn Karnauskas
Wedbush Securities Andreas Argyrides
William Blair & Company Tim Lugo


Please note that any opinions, estimates or forecasts regarding BioMarin Pharmaceutical Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of BioMarin Pharmaceutical Inc. or its management. BioMarin Pharmaceutical Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.